LLY compared with RIGL: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

RIGLRigel Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

RIGLRigel Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

RIGL

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.9%▲+4.60%×0.36

May 6 '26±16.4%▼−5.06%×0.31

= impliedLLY realized, solidRIGL realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

Q1 FY26

±15.5%

▼−10.27%

×0.66

Jan 12 '26±10.6%▼−2.15%×0.20

LLYELI Lilly & Co

1,362.23▼−0.18%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

RIGLRigel Pharmaceuticals Inc

40.00▼−12.49%

Regular sessionNov 6 '26

Mkt cap$860.7MRevenue$81MQ3 FY26Revenue$294MFY25

Compare

Regular sessionNov 6 '26

LLYELI Lilly & Co

RIGLRigel Pharmaceuticals Inc

1,362.23▼−0.18%

Price

40.00▼−12.49%

$1.2T

Mkt cap

$860.7M

Q3 FY26$24.4B

Revenue

$81MQ3 FY26

FY25$65.2B

Revenue

$294MFY25

LLY1,362.23▼−0.18%vsRIGL40.00▼−12.49%Regular sessionNov 6 '26